Regulatory dendritic cells restrain NK cell IFN-γ production through mechanisms involving NKp46, IL-10, and MHC class I-specific inhibitory receptors

Journal of Immunology

Volumn 195, Issue 5, 2015, Pages 2141-2148

  Spallanzani, Raúl G ^a   Torres, Nicolás I ^a   Avila, Damián E ^a,b   Ziblat, Andrea ^a   Raffo Iraolagoitia, Ximena L ^a   Rossi, Lucas E ^a   Domaica, Carolina I ^a   Fuertes, Mercedes B ^a,c   Rabinovich, Gabriel A ^a,c   Zwirner, Norberto W ^a,c  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b FACULTAD DE CIENCIAS EXACTAS   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; COLECALCIFEROL; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2 RECEPTOR ALPHA; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; GLUCOCORTICOID; HLA ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; VITAMIN;

APOPTOSIS; ARTICLE; CELL FUNCTION; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL; PRIORITY JOURNAL; UPREGULATION; BIOSYNTHESIS; CELL COMMUNICATION; CELL CULTURE; DRUG EFFECTS; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

CELL COMMUNICATION; CELLS, CULTURED; CHOLECALCIFEROL; COSTIMULATORY AND INHIBITORY T-CELL RECEPTORS; DENDRITIC CELLS; DEXAMETHASONE; FLOW CYTOMETRY; GLUCOCORTICOIDS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-18; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; RECEPTOR CROSS-TALK; VITAMINS;

EID: 84940122129     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1403161     Document Type: Article

References (62)

1. Ferlazzo, G., M. Pack, D. Thomas, C. Paludan, D. Schmid, T. Strowig, G. Bougras, W. A. Muller, L. Moretta, and C. Münz. 2004. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Natl. Acad. Sci. USA 101: 16606-16611.
2. Martín-Fontecha, A., L. L. Thomsen, S. Brett, C. Gerard, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2004. Induced recruitment of NK cells to lymph nodes provides IFN-γamma for T(H)1 priming. Nat. Immunol. 5: 1260-1265.
3. Ferlazzo, G., M. L. Tsang, L. Moretta, G. Melioli, R. M. Steinman, and C. Münz. 2002. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195: 343-351.
4. Pende, D., R. Castriconi, P. Romagnani, G. M. Spaggiari, S. Marcenaro, A. Dondero, E. Lazzeri, L. Lasagni, S. Martini, P. Rivera, et al. 2006. Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction. Blood 107: 2030-2036.
5. Spaggiari, G. M., R. Carosio, D. Pende, S. Marcenaro, P. Rivera, M. R. Zocchi, L. Moretta, and A. Poggi. 2001. NK cell-mediated lysis of autologous antigenpresenting cells is triggered by the engagement of the phosphatidylinositol 3- kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. Eur. J. Immunol. 31: 1656-1665.
6. Walzer, T., M. Dalod, S. H. Robbins, L. Zitvogel, and E. Vivier. 2005. Natural-killer cells and dendritic cells: "l'union fait la force." Blood 106: 2252-2258.
7. Moretta, A. 2002. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat. Rev. Immunol. 2: 957-964.
8. Lanier, L. L. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9: 495-502.
9. Moretta, A., E. Marcenaro, S. Parolini, G. Ferlazzo, and L. Moretta. 2008. NK cells at the interface between innate and adaptive immunity. Cell Death Differ. 15: 226-233.
10. Bartel, Y., B. Bauer, and A. Steinle. 2013. Modulation of NK cell function by genetically coupled C-type lectin-like receptor/ligand pairs encoded in the human natural killer gene complex. Front. Immunol. 4: 362.
11. Nikolic, T., and B. O. Roep. 2013. Regulatory multitasking of tolerogenic dendritic cells: lessons taken from vitamin d3-treated tolerogenic dendritic cells. Front. Immunol. 4: 113.
12. Schmidt, S. V., A. C. Nino-Castro, and J. L. Schultze. 2012. Regulatory dendritic cells: there is more than just immune activation. Front. Immunol. 3: 274.
13. Hargadon, K. M. 2013. Tumor-altered dendritic cell function: implications for anti-tumor immunity. Front. Immunol. 4: 192.
14. Bakdash, G., S. P. Sittig, T. van Dijk, C. G. Figdor, and I. J. de Vries. 2013. The nature of activatory and tolerogenic dendritic cell-derived signal II. Front. Immunol. 4: 53.
15. Hubo, M., B. Trinschek, F. Kryczanowsky, A. Tuettenberg, K. Steinbrink, and H. Jonuleit. 2013. Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells. Front. Immunol. 4: 82.
16. Mailliard, R. B., Y. I. Son, R. Redlinger, P. T. Coates, A. Giermasz, P. A. Morel, W. J. Storkus, and P. Kalinski. 2003. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J. Immunol. 171: 2366-2373.
17. Bellone, G., A. Carbone, C. Smirne, T. Scirelli, A. Buffolino, A. Novarino, A. Stacchini, O. Bertetto, G. Palestro, C. Sorio, et al. 2006. Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells. J. Immunol. 177: 3448-3460.
18. Kerkar, S. P., and N. P. Restifo. 2012. Cellular constituents of immune escape within the tumor microenvironment. Cancer Res. 72: 3125-3130.
19. Rabinovich, G. A., D. Gabrilovich, and E. M. Sotomayor. 2007. Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 25: 267-296.
20. Ilarregui, J. M., D. O. Croci, G. A. Bianco, M. A. Toscano, M. Salatino, M. E. Vermeulen, J. R. Geffner, and G. A. Rabinovich. 2009. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat. Immunol. 10: 981-991.
21. Torres-Aguilar, H., M. Blank, L. J. Jara, and Y. Shoenfeld. 2010. Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunity. Autoimmun. Rev. 10: 8-17.
22. Morelli, A. E., and A. W. Thomson. 2007. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7: 610-621.
23. Anderson, A. E., B. L. Sayers, M. A. Haniffa, D. J. Swan, J. Diboll, X. N. Wang, J. D. Isaacs, and C. M. Hilkens. 2008. Differential regulation of naive and memory CD4+ T cells by alternatively activated dendritic cells. J. Leukoc. Biol. 84: 124-133.
24. Boks, M. A., J. R. Kager-Groenland, M. S. Haasjes, J. J. Zwaginga, S. M. van Ham, and A. ten Brinke. 2012. IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction - a comparative study of human clinical-applicable DC. Clin. Immunol. 142: 332-342.
25. Steinbrink, K., H. Jonuleit, G. Müller, G. Schuler, J. Knop, and A. H. Enk. 1999. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood 93: 1634-1642.
26. Belladonna, M. L., C. Volpi, R. Bianchi, C. Vacca, C. Orabona, M. T. Pallotta, L. Boon, S. Gizzi, M. C. Fioretti, U. Grohmann, and P. Puccetti. 2008. Cutting edge: autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. J. Immunol. 181: 5194-5198.
27. Chorny, A., E. Gonzalez-Rey, A. Fernandez-Martin, D. Pozo, D. Ganea, and M. Delgado. 2005. Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders. Proc. Natl. Acad. Sci. USA 102: 13562-13567.
28. Unger, W. W., S. Laban, F. S. Kleijwegt, A. R. van der Slik, and B. O. Roep. 2009. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur. J. Immunol. 39: 3147-3159.
29. Bosma, B. M., H. J. Metselaar, N. M. Nagtzaam, R. de Haan, S. Mancham, L. J. van der Laan, E. J. Kuipers, and J. Kwekkeboom. 2008. Dexamethasone transforms lipopolysaccharide-stimulated human blood myeloid dendritic cells into myeloid dendritic cells that prime interleukin-10 production in T cells. Immunology 125: 91-100.
30. Rabinovich, G. A., and M. A. Toscano. 2009. Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat. Rev. Immunol. 9: 338-352.
31. Munn, D. H., M. D. Sharma, J. R. Lee, K. G. Jhaver, T. S. Johnson, D. B. Keskin, B. Marshall, P. Chandler, S. J. Antonia, R. Burgess, et al. 2002. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297: 1867-1870.
32. Nguyen, N. T., A. Kimura, T. Nakahama, I. Chinen, K. Masuda, K. Nohara, Y. Fujii-Kuriyama, and T. Kishimoto. 2010. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc. Natl. Acad. Sci. USA 107: 19961-19966.
33. Ouyang, J., P. Juszczynski, S. J. Rodig, M. R. Green, E. O'Donnell, T. Currie, M. Armant, K. Takeyama, S. Monti, G. A. Rabinovich, et al. 2011. Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders. Blood 117: 4315-4322.
34. Girart, M. V., M. B. Fuertes, C. I. Domaica, L. E. Rossi, and N. W. Zwirner. 2007. Engagement of TLR3, TLR7, and NKG2D regulate IFN-γamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12. J. Immunol. 179: 3472-3479.
35. Ziblat, A., C. I. Domaica, R. G. Spallanzani, X. L. Iraolagoitia, L. E. Rossi, D. E. Avila, N. I. Torres, M. B. Fuertes, and N. W. Zwirner. 2015. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur. J. Immunol. 45: 192-202.
36. Chiossone, L., C. Vitale, F. Cottalasso, S. Moretti, B. Azzarone, L. Moretta, and M. C. Mingari. 2007. Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells. Blood 109: 3767-3775.
37. Narni-Mancinelli, E., B. N. Jaeger, C. Bernat, A. Fenis, S. Kung, A. De Gassart, S. Mahmood, M. Gut, S. C. Heath, J. Estellé, et al. 2012. Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses. Science 335: 344-348.
38. Szabo, S. J., B. M. Sullivan, C. Stemmann, A. R. Satoskar, B. P. Sleckman, and L. H. Glimcher. 2002. Distinct effects of T-bet in TH1 lineage commitment and IFN-γamma production in CD4 and CD8 T cells. Science 295: 338-342.
39. Fernandez, N. C., A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E. Maraskovsky, and L. Zitvogel. 1999. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5: 405-411.
40. Gerosa, F., A. Gobbi, P. Zorzi, S. Burg, F. Briere, G. Carra, and G. Trinchieri. 2005. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J. Immunol. 174: 727-734.
41. Kalinski, P., A. Giermasz, Y. Nakamura, P. Basse, W. J. Storkus, J. M. Kirkwood, and R. B. Mailliard. 2005. Helper role of NK cells during the induction of anticancer responses by dendritic cells. Mol. Immunol. 42: 535-539.
42. Kobayashi, H., S. Dubois, N. Sato, H. Sabzevari, Y. Sakai, T. A. Waldmann, and Y. Tagaya. 2005. Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance. Blood 105: 721-727.
43. Koka, R., P. Burkett, M. Chien, S. Chai, D. L. Boone, and A. Ma. 2004. Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells. J. Immunol. 173: 3594-3598.
44. Lucas, M., W. Schachterle, K. Oberle, P. Aichele, and A. Diefenbach. 2007. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26: 503-517.
45. Newman, K. C., and E. M. Riley. 2007. Whatever turns you on: accessory-celldependent activation of NK cells by pathogens. Nat. Rev. Immunol. 7: 279-291.
46. Pallandre, J. R., K. Krzewski, R. Bedel, B. Ryffel, A. Caignard, P. S. Rohrlich, X. Pivot, P. Tiberghien, L. Zitvogel, J. L. Strominger, and C. Borg. 2008. Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activation. Blood 112: 4420-4424.
47. Semino, C., G. Angelini, A. Poggi, and A. Rubartelli. 2005. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 106: 609-616.
48. Vitale, M., M. Della Chiesa, S. Carlomagno, D. Pende, M. Aricò, L. Moretta, and A. Moretta. 2005. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 106: 566-571.
49. Vitale, M., M. Della Chiesa, S. Carlomagno, C. Romagnani, A. Thiel, L. Moretta, and A. Moretta. 2004. The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferongamma production upon interaction with dendritic cells. Eur. J. Immunol. 34: 1715-1722.
50. Walzer, T., M. Dalod, E. Vivier, and L. Zitvogel. 2005. Natural killer celldendritic cell crosstalk in the initiation of immune responses. Expert Opin. Biol. Ther. 5(Suppl. 1): S49-S59.
51. Borg, C., A. Jalil, D. Laderach, K. Maruyama, H. Wakasugi, S. Charrier, B. Ryffel, A. Cambi, C. Figdor, W. Vainchenker, et al. 2004. NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 104: 3267-3275.
52. Gerosa, F., B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195: 327-333.
53. Della Chiesa, M., M. Vitale, S. Carlomagno, G. Ferlazzo, L. Moretta, and A. Moretta. 2003. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur. J. Immunol. 33: 1657-1666.
54. Fehniger, T. A., M. H. Shah, M. J. Turner, J. B. VanDeusen, S. P. Whitman, M. A. Cooper, K. Suzuki, M. Wechser, F. Goodsaid, and M. A. Caligiuri. 1999. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J. Immunol. 162: 4511-4520.
55. Zwirner, N. W., and C. I. Domaica. 2010. Cytokine regulation of natural killer cell effector functions. Biofactors 36: 274-288.
56. Wong, J. L., E. Berk, R. P. Edwards, and P. Kalinski. 2013. IL-18-primed helper NK cells collaborate with dendritic cells to promote recruitment of effector CD8+ T cells to the tumor microenvironment. Cancer Res. 73: 4653-4662.
57. Wong, J. L., R. Muthuswamy, D. L. Bartlett, and P. Kalinski. 2013. IL-18-based combinatorial adjuvants promote the intranodal production of CCL19 by NK cells and dendritic cells of cancer patients. OncoImmunology 2: e26245.
58. Borrego, F., J. Kabat, D. K. Kim, L. Lieto, K. Maasho, J. Peñ a, R. Solana, and J. E. Coligan. 2002. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol. Immunol. 38: 637-660.
59. López-Botet, M., M. Llano, F. Navarro, and T. Bellón. 2000. NK cell recognition of non-classical HLA class I molecules. Semin. Immunol. 12: 109-119.
60. Colonna, M., H. Nakajima, and M. Cella. 1999. Inhibitory and activating receptors involved in immune surveillance by human NK and myeloid cells. J. Leukoc. Biol. 66: 718-722.
61. Magri, G., A. Muntasell, N. Romo, A. Sáez-Borderías, D. Pende, D. E. Geraghty, H. Hengel, A. Angulo, A. Moretta, and M. López-Botet. 2011. NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 117: 848-856.
62. Draghi, M., A. Pashine, B. Sanjanwala, K. Gendzekhadze, C. Cantoni, D. Cosman, A. Moretta, N. M. Valiante, and P. Parham. 2007. NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection. J. Immunol. 178: 2688-2698.